Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E B Bortey

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Biopharmaceutical Statistics|January 1, 1991
Testing for consistency in a single multicenter trialV M Chinchilli, E B Bortey
Journal of Biopharmaceutical Statistics|January 1, 1991
Applying survival methodology to adverse experience occurrences in controlled clinical trialsE B Bortey, A L Gould
Archives of Internal Medicine|October 8, 1999
A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trialH G Beebe, D L Dawson, B S Cutler, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 16, 1998
Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudicationM B Elam, J Heckman, J R Crouse, et al.
The American Journal of Medicine|November 7, 2000
A comparison of cilostazol and pentoxifylline for treating intermittent claudicationD L Dawson, B S Cutler, W R Hiatt, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Biopharmaceutical Statistics|January 1, 1991
Testing for consistency in a single multicenter trialV M Chinchilli, E B Bortey
Journal of Biopharmaceutical Statistics|January 1, 1991
Applying survival methodology to adverse experience occurrences in controlled clinical trialsE B Bortey, A L Gould
Archives of Internal Medicine|October 8, 1999
A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trialH G Beebe, D L Dawson, B S Cutler, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 16, 1998
Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudicationM B Elam, J Heckman, J R Crouse, et al.
The American Journal of Medicine|November 7, 2000
A comparison of cilostazol and pentoxifylline for treating intermittent claudicationD L Dawson, B S Cutler, W R Hiatt, et al.
Pageof 1